Retour
Fourchette du Jour
1,00 €
1,00 €
Fourchette 52 Semaines
1,00 €
1,00 €
Volume
100
Moyenne 50J / 200J
1,00 €
/
1,00 €
Clôture Précédente
1,00 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -111,1 | 0,2 |
| P/B | 729,6 | 3,0 |
| ROE % | -185,0 | 3,6 |
| Net Margin % | -124,2 | 3,8 |
| Rev Growth 5Y % | 84,3 | 9,9 |
| D/E | 0,5 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2026 |
0,00 €
0,00 € – 0,00 €
|
20,27M | 0 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2025-06-02 | N/A | -0,02 € | — |
| 2024-08-29 | N/A | -0,03 € | — |
| 2024-04-29 | N/A | -0,04 € | — |
| 2023-06-30 | N/A | -0,04 € | — |
| 2022-12-31 | N/A | -0,04 € | — |
| 2022-06-30 | N/A | -0,02 € | — |
| 2021-12-31 | N/A | -0,03 € | — |
| 2021-06-30 | N/A | -0,03 € | — |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Revenue grew 84,33% annually over 5 years — strong growth
Debt/Equity of 0,48 — conservative balance sheet
Negative free cash flow of -9,71M
PEG of 0,05 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 90,85%
Capital efficient — spends only 0,34% of revenue on capex
Croissance
Revenue Growth (5Y)
84,33%
Revenue (1Y)-6,52%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-184,98%
ROIC-338,47%
Net Margin-124,24%
Op. Margin-126,23%
Sécurité
Debt / Equity
0,48
Current Ratio0,88
Interest Coverage-236,53
Valorisation
P/E Ratio
-111,13
Forward P/EN/A
P/B Ratio729,57
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -6,52% | Revenue Growth (3Y) | 2,44% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 84,33% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 9,67M | Net Income (TTM) | -12,02M |
| ROE | -184,98% | ROA | -194,25% |
| Gross Margin | 40,37% | Operating Margin | -126,23% |
| Net Margin | -124,24% | Free Cash Flow (TTM) | -9,71M |
| ROIC | -338,47% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,48 | Current Ratio | 0,88 |
| Interest Coverage | -236,53 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -111,13 | Forward P/E | N/A |
| P/B Ratio | 729,57 | P/S Ratio | 138,06 |
| PEG Ratio | 0,05 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 65,90 | Fwd Earnings Yield | N/A |
| FCF Yield | -0,73% | ||
| Market Cap | 1,34B | Enterprise Value | 1,34B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 9,67M | 10,35M | 9,22M | 1,33M | 837 865,0 |
| Net Income | -12,02M | -11,75M | -7,13M | -7,08M | -6,29M |
| EPS (Diluted) | -0,09 | -0,12 | -0,08 | -0,08 | -0,15 |
| Gross Profit | 3,90M | 6,01M | 6,47M | -240 473,0 | 736 432,0 |
| Operating Income | -12,21M | -6,07M | -4,81M | -5,80M | -5,94M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 6,19M | 14,86M | 20,80M | 22,97M | 15,63M |
| Total Liabilities | 4,36M | 3,69M | 4,37M | 1,44M | 1,64M |
| Shareholders' Equity | 1,83M | 11,16M | 16,43M | 21,53M | 13,02M |
| Total Debt | 875 189,0 | 532 846,0 | 652 526,0 | 204 038,0 | 481 788,0 |
| Cash & Equivalents | 1,02M | 7,85M | 11,73M | 20,90M | 14,21M |
| Current Assets | 3,70M | 10,50M | 14,72M | 22,24M | 15,19M |
| Current Liabilities | 4,20M | 3,31M | 3,81M | 1,41M | 1,40M |